Top Markets
Coin of the day
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
Classifica tra le azioni #25548
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
Prezzo delle azioni
$20.01
Ultima sincronizzazione: 2025-02-21
Capitalizzazione di mercato
$48.36M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Singular Genomics Systems, Inc. (OMIC)

Categoria

Utile per Singular Genomics Systems, Inc. (OMIC)
Utile nel Sep 2024 TTM: $-86.32M
Secondo gli ultimi rapporti finanziari di Singular Genomics Systems, Inc., gli utili attuali della società sono $-86.32M. Nel 2022, la società ha registrato un utile di $-90.88M, un aumento rispetto a agli utili del 2021, che erano di $-98.77M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Singular Genomics Systems, Inc. dal 2019 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $-86.32M -8.96%
2023 $-94.82M 4.34%
2022 $-90.88M -7.99%
2021 $-98.77M 253.45%
2020 $-27.95M 126.75%
2019 $-12.32M 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$3.81B -4,508.84%
US
$4.11B -4,859.90%
FR
- -
JP
$1.59B -1,941.94%
US
- -
CH